Literature DB >> 23776172

β-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-α production by human plasmacytoid dendritic cells, and promote inflammation.

Poonam Tewary1, Gonzalo de la Rosa, Neeraj Sharma, Luis G Rodriguez, Sergey G Tarasov, O M Zack Howard, Hidekazu Shirota, Folkert Steinhagen, Dennis M Klinman, De Yang, Joost J Oppenheim.   

Abstract

Alarmins are a group of structurally diverse host defense antimicrobial peptides that are important immune activators. In this article, we present a novel role for two potent alarmins, human β-defensin 2 and 3 (HBD2 and 3), in promoting IFN-α production by human plasmacytoid dendritic cells. We demonstrate that HBD2 and 3 activate pDCs by enhancing the intracellular uptake of CpG and self DNA and promote DNA-induced IFN-α production in a TLR9-dependent manner. Both CpG and host DNA form aggregates that resemble DNA nets when combined with HBD2 and 3. Isothermal titration calorimetry studies to elucidate the nature of HBD3/CpG complexes demonstrate involvement of enthalpy-driven interactions, in addition to hydrophobic interactions, with the formation of complexes at a molar ratio of 2:1 defensin/CpG. The i.v. administration of HBD3/CpG complexes induced proinflammatory cytokines like IL-12, IFN-γ, IL-6, IFN-α, and IL-10 in serum, associated with an increased recruitment of APCs in the spleen. Subcutaneous injections of these complexes showed enhanced infiltration of inflammatory cells at the injection site, indicating a potential pathophysiological role for alarmin/DNA complexes in contributing to inflammation. Intraperitoneal immunization of HBD3/CpG complexes with OVA enhanced both cellular and humoral responses to OVA, compared with OVA/HBD3 or OVA/CPG alone, indicative of a much more potent adjuvant effect of the HBD3/CpG complexes. Thus, the ability of defensins to enhance cellular uptake of nucleic acids can lead to improved vaccine formulations by promoting their uptake by various cells, resulting in an enhanced immune response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23776172      PMCID: PMC4433160          DOI: 10.4049/jimmunol.1201648

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Antimicrobial peptides: general overview and clinical implications in human health and disease.

Authors:  Eduardo Guaní-Guerra; Teresa Santos-Mendoza; Saúl O Lugo-Reyes; Luis M Terán
Journal:  Clin Immunol       Date:  2010-01-29       Impact factor: 3.969

2.  Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.

Authors:  S Vordenbäumen; R Fischer-Betz; D Timm; O Sander; G Chehab; J Richter; E Bleck; M Schneider
Journal:  Lupus       Date:  2010-08-19       Impact factor: 2.911

Review 3.  Defensin-barbed innate immunity: clinical associations in the pediatric population.

Authors:  Mark A Underwood; Charles L Bevins
Journal:  Pediatrics       Date:  2010-05-17       Impact factor: 7.124

4.  Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2.

Authors:  Johann Röhrl; De Yang; Joost J Oppenheim; Thomas Hehlgans
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

5.  Accelerated wound healing mediated by activation of Toll-like receptor 9.

Authors:  Takashi Sato; Masaki Yamamoto; Takeshi Shimosato; Dennis M Klinman
Journal:  Wound Repair Regen       Date:  2010-10-13       Impact factor: 3.617

6.  Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.

Authors:  Poonam Tewary; De Yang; Gonzalo de la Rosa; Yana Li; Michael W Finn; Alan M Krensky; Carol Clayberger; Joost J Oppenheim
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

7.  Expression of human beta-defensins in children with chronic inflammatory bowel disease.

Authors:  Matthias Zilbauer; Andreas Jenke; Gundula Wenzel; Jan Postberg; Andreas Heusch; Alan D Phillips; Gabriele Noble-Jamieson; Franco Torrente; Camilla Salvestrini; Robert Heuschkel; Stefan Wirth
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

8.  Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.

Authors:  Nicholas Funderburg; Michael M Lederman; Zhimin Feng; Michael G Drage; Julie Jadlowsky; Clifford V Harding; Aaron Weinberg; Scott F Sieg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

9.  Human beta-defensin-3 promotes wound healing in infected diabetic wounds.

Authors:  Tobias Hirsch; Malte Spielmann; Baraa Zuhaili; Magdalena Fossum; Marie Metzig; Till Koehler; Hans-Ulrich Steinau; Feng Yao; Andrew Bruce Onderdonk; Lars Steinstraesser; Elof Eriksson
Journal:  J Gene Med       Date:  2009-03       Impact factor: 4.565

10.  Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons.

Authors:  Josh Gregorio; Stephan Meller; Curdin Conrad; Anna Di Nardo; Bernhard Homey; Antti Lauerma; Naoko Arai; Richard L Gallo; John Digiovanni; Michel Gilliet
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

View more
  43 in total

Review 1.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.

Authors:  Ashley L Hilchie; Kelli Wuerth; Robert E W Hancock
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

Review 2.  [Pathogenesis of psoriasis].

Authors:  K Schäkel; M P Schön; K Ghoreschi
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 3.  Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets.

Authors:  Christie M Sayes; Herman Staats; Anthony J Hickey
Journal:  Pharm Res       Date:  2014-06-12       Impact factor: 4.200

Review 4.  Antimicrobial host defence peptides: functions and clinical potential.

Authors:  Neeloffer Mookherjee; Marilyn A Anderson; Henk P Haagsman; Donald J Davidson
Journal:  Nat Rev Drug Discov       Date:  2020-02-27       Impact factor: 84.694

Review 5.  The immunology of host defence peptides: beyond antimicrobial activity.

Authors:  Robert E W Hancock; Evan F Haney; Erin E Gill
Journal:  Nat Rev Immunol       Date:  2016-04-18       Impact factor: 53.106

6.  Liquid-crystalline ordering of antimicrobial peptide-DNA complexes controls TLR9 activation.

Authors:  Nathan W Schmidt; Fan Jin; Roberto Lande; Tine Curk; Wujing Xian; Calvin Lee; Loredana Frasca; Daan Frenkel; Jure Dobnikar; Michel Gilliet; Gerard C L Wong
Journal:  Nat Mater       Date:  2015-06-08       Impact factor: 43.841

7.  Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.

Authors:  Michael R Yeaman; Scott G Filler; Siyang Chaili; Kevin Barr; Huiyuan Wang; Deborah Kupferwasser; John P Hennessey; Yue Fu; Clint S Schmidt; John E Edwards; Yan Q Xiong; Ashraf S Ibrahim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Alarmin human α defensin HNP1 activates plasmacytoid dendritic cells by triggering NF-κB and IRF1 signaling pathways.

Authors:  Fang Wang; Linan Qiao; Xing Lv; Anna Trivett; Rui Yang; Joost J Oppenheim; Ning Zhang
Journal:  Cytokine       Date:  2016-03-28       Impact factor: 3.861

Review 9.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

Review 10.  Recent progress concerning CpG DNA and its use as a vaccine adjuvant.

Authors:  Hidekazu Shirota; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2013-11-26       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.